ASTRO-group with Dr. FieldsEvery year, the American Society for Radiation Oncology (ASTRO) — the world’s leading professional society for physicians, biologists, physicists, radiation therapists, dosimetrists and other healthcare professionals specializing in radiation therapy — holds a multi-day conference for members to network, share research findings, learn from one another and discuss developments in the field of radiation oncology. This year, the highly anticipated ASTRO Annual Meeting took place in Chicago, Illinois during September. 

Despite our department’s relatively small footprint at VCU, we’re thrilled that about a dozen of our own residents, alumni and faculty members participated in this year’s conference, along with medical students with a special interest in radiation oncology. The department’s involvement includes the following:  


Laurie Cuttino, M.D.  

  • Initial report on ACOSOG Z11102 Allianz Trial: The feasibility of radiotherapy after breast-conserving surgery for multiple ipsilateral breast cancer  

Payal Soni, M.D.  

  • Moderator: Prostate and bladder mini orals


David Cooper, PGY-5 

  • Comparing maximum dose to central airways in mid-ventilations vs. average intensity projection-based 4DCT planning for lung stereotactic body radiation therapy 

Josh Dault, PGY-4 

  • What are we actually treating? A hands-on imagine verification workshop for medical and physics residents 

Christopher McLaughlin, PGY-5  

  • Patient outcomes with and without radiotherapy for early-stage Hodgkin’s lymphoma in the post-PET era 
  • Patient survival with and without radiotherapy for early-stage diffuse large B-cell lymphoma in the era of PET and rituximab 

Anthony Ricco, PGY-4  

  • T1 mapping and cardiac MRI in the detection of cardiac toxicity from radiotherapy 
  • Long-term outcomes following repeat radiation therapy to the long for lung cancer and lung metastases with stereotactic body radiation therapy  

Raj Singh, PGY-2 

  • Stereotactic body radiation therapy for metastatic renal cell carcinoma: A preliminary retrospective multi-institutional analysis 

Alexander Slade, PGY-5  

  • Diabetes self-management among cancer survivors: Differences by diagnosis and treatment 

Medical Students 

Yasamin Sharifzadeh, Medical Student  

  • Perceptions of the risks and benefits of adjuvant breast radiotherapy: The influence of provider specialty  
  • Attitudes and perceptions toward radiation therapy in breast cancer patients: the role of a multidisciplinary care team  


Matthew Manning, M.D.  

  • A prospective multi-institutional trial to resolve black-white disparities in the treatment of early-stage lung cancer  
  • Proposed hydrogel implant quality score (HIQS) for prostate radiotherapy 

Jenna Kahn, M.D.   

  • Assessment of lymphoma and other hematologic malignancy training needs amongst radiation oncology residents 

ASTRO’s next conference will take place Oct. 25-28, 2020 in Miami, Florida. The event will include opportunities for colleague networking, a collaborative innovation hub with digital posters, sessions highlighting the previous year’s advances and potential breakthroughs and a showcase featuring new products and services. 

Learn more about the 2020 ASTRO Annual Meeting here.